
Nanox reports $4.2 million Q2 revenue
Nanox (NASDAQ:NNOX) reported second quarter 2026 revenue of $4.2 million, increasing 37% year over year as teleradiology and AI software sales contributed to results.
NANO-X IMAGING (NASDAQ:NNOX), an innovative medical imaging technology company, today reported financial results for the fourth quarter ended December 31, 2025.
Nano-X Imaging (NASDAQ:NNOX) reported Q1 2026 revenue of $4.3 million, up from $2.8 million a year earlier, while net loss reached $14.3 million.
Nanox (NASDAQ:NNOX) said its Nanox AI subsidiary entered a three-year agreement giving Vertec Scientific exclusive rights to market and resell HealthOST in the United Kingdom.